Timothy Power | VP & Head, IR |
Giovanni Caforio | Chairman & CEO |
David Elkins | EVP & CFO |
Christopher Boerner | EVP & Chief Commercialization Officer |
Samit Hirawat | EVP & Chief Medical Officer, Global Drug Development |
Geoffrey Meacham | Bank of America Merrill Lynch |
Terence Flynn | Goldman Sachs Group |
Stephen Scala | Cowen and Company |
Seamus Fernandez | Guggenheim Securities |
Christopher Schott | JPMorgan Chase & Co. |
Timothy Anderson | Wolfe Research |
David Risinger | Morgan Stanley |
Aaron Gal | Sanford C. Bernstein & Co. |
Luisa Hector | Berenberg |
Andrew Baum | Citigroup |
Good day, and welcome to the Bristol-Myers Squibb 2020 Fourth Quarter Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Tim Power, Vice President, Investor Relations. Please go ahead, sir.